Form 4: Health Catalyst Executive Linda Llewelyn Sells 2,005 Shares
SEC Form 4 Filing
Linda Llewelyn, Chief People Officer of Health Catalyst, Inc., sold 2,005 shares of common stock at a price of $7.8043 per share on March 15, 2024, according to a Form 4 filing.
Summary
- Linda Llewelyn, the Chief People Officer of Health Catalyst, Inc. (HCAT), reported a transaction involving the company's common stock.
- On March 15, 2024, Llewelyn sold 2,005 shares of common stock at a price of $7.8043 per share.
- Following the transaction, Llewelyn directly owns 128,231 shares of Health Catalyst common stock.
- The sale was executed under a pre-arranged trading plan adopted on May 23, 2023, in accordance with Rule 10b5-1.
Sentiment
Score: 5
Explanation: Neutral sentiment as the transaction was pre-planned under Rule 10b5-1 and doesn't necessarily reflect the executive's current view of the company's performance.
Industry Context
Insider transactions are routinely monitored by investors to gauge executive sentiment regarding the company's prospects. A sale doesn't necessarily indicate a negative outlook, especially when executed under a pre-arranged trading plan.
Stakeholder Impact
- The sale of shares by an executive may cause short-term concern among shareholders, but the pre-planned nature of the transaction mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 05/23/2023 | Date of adoption of the written trading plan in accordance with Rule 10b5-1. |
| 03/15/2024 | Date of the transaction (sale of common stock). |
| 03/19/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.